1
Prabhu Mohapatra
Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey: Compositions, synthesis, and methods of utilizing arylpiperazine derivatives. Reviva Pharmaceuticals, Perkins Coie, Viola T Kung, May 29, 2012: US08188076 (1 worldwide citation)

The present invention provides arylpiperazine derivatives having Formula I which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.


2

3

4
Laxminarayan Bhat, Prabhu Prasad Mohapatra, Kouacou Adiey: Compositions, synthesis, and methods of utilizing arylpiperazine derivatives. Fenwick & West, August 26, 2010: US20100216783-A1

The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.


5
BHAT LAXMINARAYAN: Compositions, synthesis, and methods of utilizing arylpiperazine derivatives. REVIVA PHARMACEUTICALS, Harwood Melissa M, September 2, 2010: WO/2010/099502

The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.


6

7
Bhat Laxminarayan, Mohapatra Prabhu Prasad, Adiey Kouacou: Compositions, synthesis, and methods of utilizing arylpiperazine derivatives. Reviva Pharmaceuticals, li jin liu jian, April 11, 2012: CN201080019233

The present invention provides arylpiperazine derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression.


8
BHAT LAXMINARAYAN, MOHAPATRA PRABHU PRASAD, ADIEY KOUACOU: COMPOSITION, SYNTHESES ET PROCEDES DUTILISATION DES DERIVES DARYLPIPERAZINE, COMPOSITIONS, SYNTHESIS, AND METHODS OF UTILIZING ARYLPIPERAZINE DERIVATIVES. REVIVA PHARMACEUTICALS, REVIVA PHARMACEUTICALS, GOWLING WLG, March 14, 2017: CA2753599

The present invention provides arylpiperazine derivatives of Formula I which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder and depression. (see formula 1)